These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7438 related articles for article (PubMed ID: 17713027)

  • 1. Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines.
    Kadagidze ZG; Borunova AA; Zabotina TN
    Adv Exp Med Biol; 2007; 601():381-6. PubMed ID: 17713027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
    Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J
    Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in perforin-positive peripheral blood lymphocyte (PBL) subpopulations following exercise.
    Staats R; Balkow S; Sorichter S; Northoff H; Matthys H; Luttmann W; Berg A; Virchow JC
    Clin Exp Immunol; 2000 Jun; 120(3):434-9. PubMed ID: 10844520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
    Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
    Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative changes in characteristics of immunity in longlivers].
    Stolpnikova VN; Kochergina NI; Karpenko OM; Miroshnichenko IV
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):50-3. PubMed ID: 17163140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients.
    Aarntzen EH; Schreibelt G; Bol K; Lesterhuis WJ; Croockewit AJ; de Wilt JH; van Rossum MM; Blokx WA; Jacobs JF; Duiveman-de Boer T; Schuurhuis DH; Mus R; Thielemans K; de Vries IJ; Figdor CG; Punt CJ; Adema GJ
    Clin Cancer Res; 2012 Oct; 18(19):5460-70. PubMed ID: 22896657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific T-cell help is associated with improved survival in melanoma.
    Woods K; Cebon J
    Clin Cancer Res; 2013 Aug; 19(15):4021-3. PubMed ID: 23864163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
    Di Pucchio T; Pilla L; Capone I; Ferrantini M; Montefiore E; Urbani F; Patuzzo R; Pennacchioli E; Santinami M; Cova A; Sovena G; Arienti F; Lombardo C; Lombardi A; Caporaso P; D'Atri S; Marchetti P; Bonmassar E; Parmiani G; Belardelli F; Rivoltini L
    Cancer Res; 2006 May; 66(9):4943-51. PubMed ID: 16651452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
    Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
    Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
    Harlin H; Kuna TV; Peterson AC; Meng Y; Gajewski TF
    Cancer Immunol Immunother; 2006 Oct; 55(10):1185-97. PubMed ID: 16468035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans.
    Autissier P; Soulas C; Burdo TH; Williams KC
    Cytometry A; 2010 May; 77(5):410-9. PubMed ID: 20099249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
    Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of melanoma vaccines and promising approaches.
    Panelli MC; Wang E; Monsurrò V; Jin P; Zavaglia K; Smith K; Ngalame Y; Marincola FM
    Curr Oncol Rep; 2004 Sep; 6(5):414-20. PubMed ID: 15291987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 372.